Rampart Bioscience, Inc.

Research and development related to viral and non-viral vectors and delivery of viral and non-viral vectors; research and development of biological and pharmaceutical preparations to treat diseases utilizing a proprietary discovery platform; conducting early evaluations in the field of new pharmaceutical and biopharmaceutical products

Genetically engineered cell lines for medical purposes; cell lines for medical purposes; cells for medical or clinical use; Cell lines for scientific, laboratory and medical research purposes; cell lines for biologic production for scientific, laboratory and medical research purposes; recombinant cell lines for scientific, laboratory and medical research purposes; cell lines adapted for the transfection, expression and production of recombinant proteins, macromolecules and biologics for scientific, laboratory and medical research purposes; genetically engineered cell lines for scientific, laboratory or medical research purposes; Biotechnology research and development services for developing cell lines for protein expression or production for others

Pharmaceutical preparations, biological preparations and gene therapy products for the treatment of genetic disorders and diseases; pharmaceutical preparations for gene therapy and gene editing; pharmaceutical preparations for the treatment of disorders of the metabolic system; genetically modified cells and viral vectors for the treatment of diseases, namely, genetic diseases, excluding dietary supplement and nutritional supplements and meal replacement mixes and excluding any charitable fund raising services; Pharmaceutical research and development; development of pharmaceutical preparations and drugs; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs in the fields of biotechnology and gene therapy, excluding any research or development involving dietary supplements and nutritional supplements or meal replacement mixes and excluding any charitable fund raising services

Gene therapy products, namely, genetically engineered viral and non-viral vectors for gene delivery or protein expression from the gene; gene therapy delivery agents, namely, viral and non-viral vectors for gene delivery or protein expression from the gene; pharmaceutical preparations for treating genetic disorders, namely, viral and non-viral vectors for delivering therapeutic agents; Research and development related to viral vectors and delivery of viral vectors; research and development related to non-viral vectors and delivery of non-viral vectors; research and development related to viral and non-viral vectors for delivering therapeutic agents

Providing online non-downloadable software via a web-based clinical and patient portal that permits the collection and distribution of information regarding therapeutics, treatment and research; providing temporary use of a web-based software application for use in clinical trials and clinical development to inform patients; providing temporary use of a web-based software application for use in clinical trials and clinical development to collect data; providing temporary use of a web-based software application for use in clinical trials and clinical development to track clinical developments; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to inform patients; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to collect data; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to track clinical developments